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Background: In 2015, 3292 New Zealand women were diagnosed with breast cancer. A 
breast cancer diagnosis tends to evoke lifestyle change and in particular dietary change. There 
is a substantial amount of research about the potential causes of breast cancer and dietary risk 
factors, but less on diet during breast cancer treatment and even less on what women are 
consuming post treatment completion. There can be lasting impacts from treatment including 
poor nutrient intake, unwanted weight change and undesirable weight changes. These affect 
nutritional status and possibly recurrence risk. To date, the guidelines for what breast cancer 
survivors should consume post treatment are based on limited, but suggestive evidence for 
reducing the risk of recurrence. There is a lack of research on dietary habits in women with 
breast cancer in this country. In order to potentially influence lifestyle changes, it is important 
that breast cancer survivors have their actual diet documented.  
 
Objective: The aim of this thesis is to describe the diet in breast cancer survivors and 
compare it to recommendations and guidelines. This will guide further research in this area, 
here in New Zealand and potentially aid the production of specific national dietary 
recommendations for breast cancer survivors. 
 
Design: This is a descriptive pilot study of women participating in the EXPINKT™ 
programme in Dunedin who completed breast cancer treatment at least six weeks prior. 
Participants received a questionnaire including a section on characteristics and a Food 
Frequency Questionnaire (FFQ), measuring dietary intake for the preceding three months.  
 
Results: The questionnaire was returned by 35 women. Nutrient intakes derived from the 




group. The cohort did not meet the Ministry of Health recommendations for the food groups 
of vegetables, meat, poultry and seafood as well as breads and cereals. There were no 
meaningful differences for any nutrients between treatments, although of the women who 
received either chemotherapy or hormone therapy, nutrient intakes tended to be higher than 
those women who did not receive that treatment. There were meaningful differences for 
protein 22.8 g (95 % CI: 1.64, 43.9), riboflavin 0.88 mg (95 % CI: 0.11, 1.64), folate 162 µg 
(95 % CI: 22.4, 301), calcium 587 mg (95 % CI: 99.7, 1074), zinc 3.21 mg (95 % CI: 0.23, 
6.20) and potassium 1153 mg (95 % CI: 85.7, 2220) in women that were diagnosed prior to 
2013 as their confidence intervals did not cross zero. Education level and body mass index 
status had no association with nutrient intake, although a lack of tertiary education was 
associated with a lower intake of all food groups.  
 
Conclusion: Dunedin breast cancer survivors who participate in the EXPINKT™ programme 
do not meet the Ministry of Health’s food group recommendations for vegetables, meats and 
breads and cereals. To prevent the negative outcomes that may occur, there is a need for 
nutritional guidance in this population, particularly in New Zealand. Continued research is 
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Breast Cancer (BC) has been estimated to be responsible for 627,000 deaths worldwide in 
2018 (1) and 641 deaths in New Zealand (NZ) in 2013, 633 of whom were women (2). Over 
1.5 million people per year internationally are diagnosed with BC, with 3292 new cases 
diagnosed in NZ in 2015 (3). Almost half of those women were aged between 45 and 64 years 
(3). 
 
There is ongoing research into BC and the factors that can increase or decrease the risk of 
developing the disease (4). Several lifestyle-related factors have been identified to decrease 
BC risk. These are vigorous physical activity, greater body fatness in young adulthood and 
lactation (5). Factors that have been found to increase risk of BC in postmenopausal women 
include consuming alcoholic drinks, greater body fatness throughout adulthood, greater 
weight gain throughout adulthood and factors leading to increased linear growth. Some 
dietary factors have been linked with decreasing the risk of development, these include non-
starchy vegetables, carotenoids, dairy products and calcium (5). 
 
While there is a deal of research investigating the role of diet in the prevention of cancer and 
BC, there is less information available discussing the role of diet in BC survivors or data 
describing their dietary intake post treatment. There is no reliable evidence for determining 
the best diet for BC survivors. Although, evidence indicates that a diet that intends to prevent 
primary cancer could also help with maintaining a disease free status (5). 
 
There are currently several treatment options used in BC. These include surgery, 




associated with these treatments including weight gain, weight loss, change of taste 
perception, nausea and fatigue (7). 
 
The term ‘BC survivor’ is defined in a number of ways throughout the literature. The 
internationally accepted definition is that someone from the day of diagnosis is a cancer 
survivor.  
 
There is currently no data from NZ populations that describe the dietary intake of BC 
survivors. This thesis is purely exploratory and descriptive. It is outside the scope of this 
thesis to look at treatment types and types of BC themselves. This area of research is a 
minefield, and the overall aim of this thesis is to describe the diet in a group of BC survivors 
from Dunedin and the surrounding areas and compare it to recommendations and guidelines. 
This will guide further research in this area in NZ and potentially advise the creation of 
specific national dietary recommendations for BC survivors.  
 
This literature review summarises the relevant evidence surrounding BC and dietary intake. 
The majority of research has focused on dietary exposures before BC diagnosis and during 
treatment. There has been little research undertaken on BC survivors i.e. post treatment and 








2. Literature Review 
2.1 Literature Review Search Methodology  
The article databases Web of Science, Scopus, MEDLINE and Google Scholar were searched, 
including papers from a year range of 1977 to 2018. The reference lists of relevant articles 
were also searched. The search terms included a combination of “breast cancer”, diet*, weight 
loss, treatment, food, cancer, “adult women”, “cancer treatment”, survivors, taste changes, 
nutrition*, recommendations, guidelines, review, impact, affect, intervention, malnutrition, 
intake, nutrient, micronutrient, nutrition, “food frequency questionnaire” and “Willet FFQ”. 
 
2.2 Dietary Assessment  
 
2.2.1 Dietary Techniques  
There are four main techniques commonly used to measure the dietary intake of individuals; 
24-hour recalls, food records, diet histories, and Food Frequency Questionnaires (FFQ) (8). 
The 24-hour recall method requires a trained interviewer to ask the subject to recall their 
exact food intake for the previous 24 hours or the preceding day. To gain a better 
understanding of the individual’s habitual diet, this process can be repeated over several non-
consecutive days throughout different seasons. The advantages to this assessment method are 
that it has a low respondent burden, the subjects do not need to be literate and they are not 
limited by a selection of food lists. However, the recall relies heavily on the individual’s 
memory and their ability to describe portion size. It can also be costly due to the trained 
interviewer (8). 
 
Food records can either be estimated or weighed. The subject is asked to record everything 
that they eat and drink, including the specific ingredients to recipes, over a set amount of time 




but measuring scales are used in the other. Details of how the food was prepared as well as 
the type and brand are also important and should be recorded. This method is regarded as the 
most precise dietary assessment technique and it does not rely on memory, any food can be 
recorded and portion size is documented. Although the disadvantages of this method are that 
it has a high respondent burden and requires motivated, literate and numerate respondents (8). 
 
A diet history is a detailed interview of an individual with the aim of recording their usual 
food intake over a relatively long period of time. This method requires a trained interviewer, 
it can be labour intensive, there is a heavy reliance on the individual’s memory and their 
ability to recognise portion size (8). 
 
Food frequency questionnaires aim to measure an individual’s habitual consumption of 
certain foods by listing a set list of food and drinks with a section that can be used to indicate 
how often that item is consumed and the portion size. The advantages of FFQs are that they 
are well suited to research populations, there is a low respondent burden, and they are more 
cost effective than other methods due to administration, data-entry and analysis. FFQs aim to 
capture a respondent’s usual intake of certain foods, in order to rank the individuals according 
to their standard consumption of nutrients, foods or groups of foods (9). They tend to be used 
in case control or cohort studies to assess the association between dietary intake and the risk 
of disease. Semi quantitative FFQs incorporate information about usual portion sizes (8). As 
with all methods of dietary assessment, there are some limitations associated with the use of 
FFQs. They do not usually measure absolute levels of intake of nutrients and foods. A finite 
food list means it is unable to measure the absolute intake of all nutrients and the variability 
(e.g. the brands and preparation practices) of someone’s diet in full and there are errors in 
participant estimations of frequency and serving sizes (9). FFQs are not always accurate in 




Different FFQ’s perform differently and unpredictably in different populations, despite 
sometimes producing reasonable averages. Therefore, nutrient intake results should generally 
only be deemed as approximations (9). This means that results of validation studies show that 
semi quantitative FFQs can give researchers a reliable and valid estimate of intake, although 
this tends to mostly be at the group, rather than individual, level.  
 
One of the most widely used FFQs worldwide is the Willet FFQ. In 1980 Walter Willett 
developed a semi quantitative FFQ (10) which was then validated against diet records (10). 
The Willett FFQ has been adapted for use in many countries worldwide (11) and has been 
used in many published papers, such as the renowned Nurses Health Study and the Health 
Professional Cohort Study. It has also been used in other studies such as magnesium intake 
and insulin resistance (12), dietary intake in the transition to adulthood (13), diet quality and 
mortality in older adults (13), and vitamin C and hip fractures (Framingham Osteoporosis 
Study) (14), in countries such as Canada, the United States of America (US) and Australia. 
Previous research from the Nurses Health Study and the Health Professional Cohort Study 
have shown significant and reliable associations with specific foods and the burden of several 
diseases.  
 
A New Zealand (NZ) version of this FFQ (FOOD-FFQ) was developed and its reproducibility 
and relative validity assessed (15) where 132 adult participants completed the FFQ, an eight 
day weighed food record and blood tests. The results of the validation study show that a 
single administration of the FOOD-FFQ is sufficient to provide measures with a high level of 
reliability (15). Validity correlation coefficients ranged from 0.74 (alcohol), 0.65 (cholesterol), 
0.58 (β - carotene), 0.56 (carbohydrate) and 0.56 (vitamin C) (15). This FFQ was revalidated 
in 2017 and showed similar levels of reproducibility and validity (16). The correlation 




carbohydrate and 0.56 fibre. Results of Bland-Altman analyses showed that this FFQ actually 
provides estimates of intake for all micronutrients with high agreement for protein (99 %) and 
total fat (103 %), that are suitable for use at the individual level. 
 
2.3 Breast Cancer and Nutrition  
The links between diet and Breast Cancer (BC) incidence and recurrence have been 
researched for decades. Despite this there does not appear to be any definitive or reliable 
evidence for the optimal diet in BC survivors.  
 
2.3.1 AICR/WCRF Recommendations  
The American Institute for Cancer Research/World Cancer Research Fund (AICR/WCRF) is 
the leading group for cancer research and prevention globally. The Continuous Update Project 
(4) analyses the worldwide research on how diet, nutrition and physical activity affect cancer 
risk and survival. It informs guidelines and policies for cancer prevention and survival. The 
research conclusions are used to update the Cancer Prevention Recommendations (17).  
 
The AICR/WCRF recommend that for preventing all types of cancer recurrence, people 
should follow as many of the cancer prevention recommendations (17) as possible. These are; 
be a healthy weight; be physically healthy; eat a diet that is rich in whole grains, vegetables, 
fruits and beans; limit consumption of red and processed meat; limit consumption of sugar-
sweetened drinks, limit consumption of “fast foods” and other processed foods high in fat, 
starches or sugars; limit alcohol consumption; do not use supplements for cancer prevention; 
and for mothers, breastfeed your baby if you can. They also recommend avoiding smoking 





There are currently minimal BC specific nutrition recommendations for preventing incidence 
and recurrence that are supported by strong evidence (5, 18). Most research regarding 
nutrition and BC shows limited, but suggestive, evidence for links between foods or nutrients 
and the risk of BC (5). The research for the risk of BC is influenced by menopausal status, i.e. 
premenopause and postmenopause (5). In terms of premenopausal BC, there is strong 
evidence that being overweight or obese between the ages of 18 and 30 probably decreases 
risk, whereas consuming alcoholic drinks probably increases risk (5). There is limited, but 
suggestive, evidence that consuming non-starchy vegetables, foods containing carotenoids, 
dairy products, and a diet high in calcium might decrease risk (5). The same is true for 
postmenopausal BC with the exception of dairy products as no link was mentioned (5). There 
has also been a substantial amount of research conducted into other types of foods and 
nutrients; however, the evidence is limited and inconclusive (5).  
 
The AICR/WCRF also produces a report about diet, nutrition and physical activity regarding 
BC survivors (18). The latest publication was in 2014, but revised in 2018, and the findings 
for BC survival were presented by timeframe or by outcome, which was then further 
categorised by all-cause mortality, BC-mortality and second primary BC. All of these findings 
were too limited to justify making specific recommendations, as they were only suggestive 
and inconsistent associations. The nutrients identified that show suggestive evidence for 
survival were, fibre, saturated fatty acids and soy. Body fatness and physical activity were 
also included. The conclusions for these three dietary components are that a greater 
consumption of fibre both before and after diagnosis may lower the risk of women dying from 
BC. The higher the intake of fat and saturated fat before BC development may increase 
women’s risk of dying following a diagnosis of BC. Lastly, women who have been diagnosed 
with BC and/or are in remission who have large intakes of soy may have a lower risk of dying 




to be limited and contradictory. Although, this report recommends that after BC treatment, 
people should follow the Cancer Prevention Recommendations (17) mentioned above. 
 
2.3.2 Breast Cancer and Dietary Change 
Dietary changes are one of the most common lifestyle alterations made by BC survivors (19) 
and cancer survivors will pursue advice on how to best help their cancer treatment and 
prevent recurrence (20). Still, there is limited evidence from randomised controlled trials on 
diet and prognosis (5, 18).   
 
Post diagnosis, During Treatment  
A large number of BC patients improve their diet post diagnosis; however many BC survivors 
do not initiate or continue dietary changes after treatment (19-23). A United Kingdom 
multicenter study found that 30 – 48 % of people recently diagnosed with BC significantly 
altered their diet in a positive way. The changes reflected healthy eating guidelines, with 
reduced intakes of fat, red meat and simple sugars as well as an increased intake of fruits and 
vegetables (24). Some women increase their consumption of ‘less healthy’ foods because of 
the comfort found in them while going through the negativity and uncertainty of a BC 
diagnosis and its treatment (25).  
 
Post Treatment 
There have been only two large randomised controlled trials investigating whether dietary 
change after BC affects cancer endpoints and the findings varied (26, 27). Pierce et al. (27) 
reported that increasing fruit, vegetables and fibre in the diet and decreasing fat had no effect 
on BC events or mortality. Whereas Chlebowski et al. (26) found reducing fat in the diet led 
to positive effects on cancer endpoints. The extensive amount of observational research 




recommendations for BC survivors (18). Therefore it is not surprising that a larger proportion 
of women do not initiate dietary change. In a group of 7,443 BC survivors, only 33.9 % (95 % 
CI: 31.9, 36.0) of the women consumed the recommended more than five serves of fruits and 
vegetables per day (28). After adjustment for years of survival after BC, this value had 
minimal change. Thus concluding that BC survivors’ adherence to lifestyle recommendations 
is low and that more efforts such as counselling and health education should be increased (28). 
These findings were similar to Blanchard et al. who found only 18.2 % of BC survivors were 
meeting ‘5 – A – Day’, which was similar for the other types of cancer (29). Additionally, 
another epidemiological study (30) found that in BC survivors, 58 % made positive changes 
to their diet and or physical activity, with 44 % decreasing fat intake, 42 % increasing fibre 
and 43 % increasing fruit and vegetable intake. A more recent study conducted in Malaysian 
BC survivors post treatment (31), showed that the mean fibre and calcium intakes were low 
compared to the WCRF recommendations. The mean macronutrient distributions were 56 %, 
15 % and 29 % for carbohydrate, protein and fat, respectively (31). Despite these changes, 
research does show that it is no more feasible that longer term cancer survivors will sustain a 
healthful diet, compared with non survivors of similar characteristics (19, 29, 32). In NZ there 
is limited research about what BC patients or survivors are doing in terms of their diet. 
 
2.3.3 Breast Cancer Side Effects and the Impact on Nutrition  
BC and its treatments can have countless negative impacts on the body. These include, but are 
not limited to, poor nutrient intake, unwanted weight change, undesirable taste changes, and 
fatigue. These effects can influence nutritional status, which can indirectly contribute to an 
increased risk of postoperative complications and mortality (33-35). Therefore, preventing 






Post Diagnosis, During Treatment 
To minimise the impact of BC treatment and negative outcomes for a patient, interventions 
and lifestyle changes have been suggested. However, these are not necessarily implemented, 
particularly in NZ. One suggestion is a nutrition counselling session prior to treatment. A 
critical review (36) recommends that all BC patients should receive a nutritional assessment 
immediately after diagnosis. The review highlights several reasons why this would be a 
positive arrangement for patients. Studies found that BC patients are often found to have 
insufficient intakes of calcium, iron, phosphorus, magnesium, niacin, riboflavin, thiamine, 
vitamin B6, vitamin C and zinc, which weakens their nutritional status. Although dietary 
intake was measured via repeated 24 hour recalls in these studies and so underestimation due 
to memory bias (8) may have occurred. However in one study, up to nine recalls were 
performed to combat this. Nevertheless, these vitamins and minerals are abundant in fruit, 
legumes, and dark green and orange vegetables, which have been found to be scarce in BC 
patients’ diets (36-38). The aforementioned nutrients, plus others can play an important role 
in aiding people going through treatment, as they have been linked with positive changes in 
anthropometric, metabolic, inflammation and DNA methylation markers (36, 39), therefore 
assessing nutritional status at baseline and throughout treatment is imperative. The review 
(36) recommends that the nutritional assessment should be part of their treatment routine and 
be simple, inexpensive, reliable and able to identify those who are at greater risk of nutritional 
imbalance.  
 
Weight management is another way to prevent detrimental outcomes. The mechanism for 
weight gain after diagnosis is unclear (40). Although reduced metabolism due to rapid onset 
of menopause and a reduction in physical activity all attributed to chemotherapy have been 
considered (40). The imbalance of energy expenditure and energy intake during and post 




consequences for BC patients, as does being underweight. A U – shaped curve has been 
recognised in terms of mortality and weight change (41). Weight gain is common in women 
after BC diagnosis for both pre- and postmenopausal women (42). Due to a substantial 
amount of documented information surrounding this, oncologists now counsel newly 
diagnosed women to avoid weight gain (40). Despite this, weight gain is still common (43-45). 
 
Evaluation of nutritional status in BC patients actively receiving treatment showed that obese 
patients have decreased BC specific survival (HR = 1.33, 95 % CI: 1.19, 1.50) and an 
increased risk of mortality (HR = 1.33, 95 % CI: 1.21, 1.47) when compared with non-obese 
women with BC (46). Proposed nutrition interventions for BC patients suggest limiting 
weight loss to between 5 % and 10 % of initial body weight using calorie restriction based on 
age and BMI, increasing dietary quality with nutrient dense foods and reducing the intake of 
simple sugars and added fats (7, 36, 40, 47-49). While there are risks when carrying too much 
weight, being underweight also has health risks. A US observational study (41) measured the 
effects of pre- and post-diagnosis BMI on mortality and found that women who lost 2.1 to 
10.0 kg had 1.39 times greater mortality than women who stayed within 2 kg of their pre 
diagnosis weight (95 % CI: 1.04, 1.86). Women who had lost greater than 10 kg had 2.66 
times greater mortality (95 % CI: 1.73, 4.07). There is an increased risk of complications due 
to malnutrition in BC patients who have lost > 10 % of their usual weight in less than six 
months (36), therefore a BMI range of 20 - 24.9 kg/m2 is encouraged (40, 50).  
 
One of the side effects of cancer treatment, specifically chemotherapy, is taste change (51). 
These changes can result in a decline in pleasure of eating (25) and therefore a decline in 
nutritional intake (52). Research has shown that a lower taste perception during chemotherapy 
in BC patients is associated with a lower energy intake, specifically protein and fat (53) and 




group of BC patients were questioned approximately one month after their last round of 
chemotherapy and again six months later. Their responses were compared to a group of 
women without BC (54). At the first point of questioning, 65 % of patients reported their taste 
perception as worse compared to before chemotherapy. Six months later, 76 % reported their 
taste as the same as before chemotherapy and 8 % reported better taste perception. The results 
from this study concur with others (55, 56) who reported that taste and smell perception is 
altered briefly after chemotherapy ceases, but has returned to normal six months later for most 
patients (54). Thus, BC patients post treatment are not as restricted by food taste and can have 
a greater dietary intake than when they are receiving treatment.  
 
Another side effect of cancer treatment is fatigue (57). Diet quality has also been linked with 
fatigue levels in women with BC. Fatigue may limit BC survivors’ ability to change their 
health behaviours; alternatively survivors who increase their fruit and vegetable intake 
reported less fatigue after doing so (30). When ranked into groups, a higher quality diet e.g. a 
greater intake of foods such as fruits and vegetables appeared to decrease the levels of fatigue 
in women with BC (pcontrast = 0.003), as well as behavioural and physical symptoms of fatigue 
(58). These secondary side effects of having BC begin to resolve once treatment ceases but 
can continue for some time, impacting intake and therefore nutritional status (7). They can be 
attenuated to some extent with nutrition. 
 
2.3.4 Individualised Nutrition Treatment Plans  
In NZ there are no individualised nutrition treatment plans for BC patients. Several studies 
have shown positive outcomes for BC and cancer patients that have had individualised 
treatment plans regarding nutrition and exercise (59-61). The information given to BC 




survivors would have liked to received information about health related programmes at the 
time of diagnosis or soon after (20).  
 
Post Diagnosis 
Creating individualised dietary plans or interventions for BC patients are considered to be 
‘state of the art’ (36, 62). However, they are only effective if the target population is willing 
to adhere to them. The United States Oncology Nursing Society proposed an evidence based 
nutrition intervention programme for cancer patients, which was also supported by the United 
States National Cancer Institute (36, 63). They recommended individualised nutritional 
therapy as the most effective measure for cancer patients. A dietitian would be part of the 
team, who would work with the patient and their families and also be included in the 
multidisciplinary team (36). In addition, some Australian BC patients voiced their desire to 
see a dietitian after diagnosis (25). They also would have liked to received diet management 
during treatment as well as the option of discussing dietary concerns.  
 
Post Treatment  
There have been several constructive and effective outcomes stemming from individualised 
treatment plans surrounding exercise and nutrition for BC patients post treatment. A 
randomised controlled trial (64) of 90 overweight/obese women 3 - 18 months post BC 
treatment found that individualised dietary advice and exercise sessions resulted in significant 
changes in blood biomarkers and perceived quality of life. Central adiposity also reduced, as a 
decrease in weight circumference of 3.32 cm was observed in favour of the intervention group 
(95 % CI: -1.53, -5.11; p < 0.001). Central adiposity is associated with a number of metabolic 
disorders such as elevated leptin concentration (65). These disorders are connected with 
postmenopausal cancer risk (66, 67) and poorer survival in early stage BC patients (68). The 




-16.7) and saturated fat (-4.1 g, 95 % CI: -1.2, -7.0) intake than in the control group, which 
meets recommendations by the AICR/WCRF (17). Thus implying that individualised support 
potentially can positively influence health outcomes and therefore the long-term prognosis in 
these patients (64). Rock et al. (69) also found that, overweight and obese BC survivors lost 
significantly more weight at six, twelve and eighteen months if they were in the intervention 
group that received more intensive weight loss support. The support began with weekly group 
sessions then fortnightly then monthly, plus reinforcing phone calls and/or email and 
individually tailored newsletters. All with the aim of reducing energy intake relative to 
expenditure and undertaking at least 60 minutes exercise per day (69).  
 
Conversely, an Australian study (70) that assessed the feasibility, acceptability and outcomes 
of 53 BC survivors participating in a funded lifestyle programme had mixed findings. In 
addition to other lifestyle support, women received ten personalised phone calls across six 
months, where physical activity, nutrition and weight management were discussed. Daily fruit 
and vegetable intakes showed no significant change from baseline, with no change in the 
consumption of takeaway meals per week. However, a low adherence was reported, as only 
62 % of the original cohort completed the programme.  
 
2.3.5 Breast Cancer, Diets and Micronutrients for Nutritional Therapy 
There has been extensive research published on specific foods and their properties for aiding 




In a recent review (71) of the role of dietary polyphenolics on BC recurrence, a recommended 




flavonols such as onions, broccoli, apples and citrus for early diagnosed BC patients was 
suggested.  
 
Cancer risk may increase with the consumption of meat, particularly red meat and processed 
meats (4). Women diagnosed with BC with a high intake (more than 44 times per year) of 
grilled/barbecued and smoked meat prior to diagnosis, had a 23 % increased risk (95 % CI: 
1.03, 1.46, ptrend = 0.02) of all-cause mortality compared to a low intake (0 - 43 times per 
year) (72). There was no significance in BC specific mortality for those who changed their 
high intake of smoked meat pre diagnosis to a low intake post diagnosis (HR = 1.71, 95 % CI: 
1.00, 2.92). Post diagnosis changes of the intake of grilled/barbecued poultry or fish were not 
associated with BC specific mortality. 
 
During Treatment 
The AICR recommends a diet rich in vegetables and fruit (17). An increase in fruit and 
vegetables is associated with better cancer outcomes and improved results in inflammatory 
response, tumour progression and hormonal biomarkers of recurrence risk in BC patients (39). 
During chemotherapy, dietary intake has been found to decrease over the course of treatment 
and even reaching an inadequate intake (38). In particular, intakes of fruit, orange and green 
vegetables and legumes have been found to significantly decrease over the treatment course. 
Collectively, fruits and vegetables are associated with a moderate reduction in the risk of BC 
(73); however, there is still only minimal evidence in this area. These foods are abundant in 
vitamins, minerals and antioxidants, which have several health benefitting properties. One 
fruit serving of 150 g and a vegetable serving of 75 g at 5 - 9 servings per day would supply a 
satisfactory amount of antioxidants and fibre in the diet (7, 40, 74-76). Preferably, vegetables 
should be mostly rich in β - carotene and vitamins A, E and C (77). These vitamins have been 




methylation markers (39). Vitamin B6, magnesium, riboflavin, thiamine, zinc and niacin have 
anti-inflammatory properties, which have the potential to decrease the risk of adverse health 
outcomes in cancer patients by helping the anti-inflammatory cytokine profile (78). Garlic (79, 
80) and vegetables (81, 82) from the cruciferous family have a greater antiproliferative and 
antioxidant activity in BC cells, therefore they have been recommended in the diets of BC 
patients for therapeutic nutritional intervention (83). They have also been found to contain 
bioactive compounds that have shown chemopreventive activities in all stages of BC 
carcinogenesis (84). 
 
Protein plays an important role in a cancer patient. An intake of 1.2 - 1.5 g/kg per day is said 
to prevent sarcopenic obesity as it maintains fat free mass (85, 86). It is suggested that the 
adequate sources of protein consumed are fish, poultry, turkey and pork tenderloin as they 
have a low fat content (87) and that meat, eggs and low fat dairy should make up only a small 
amount of protein sources in the diet (1 - 2 times/week each) due to their potential heightened 
risk increase of developing BC (88). 
 
Post Treatment  
The research conducted about BC survivors’ diet and its impact on several outcome measures, 
shows positive associations when ‘healthier’ diets are followed. A recent systematic review 
(89) looked at seven studies that had measured the dietary intake of BC survivors and 
mortality. Two found that a prudent/healthy diet was significantly associated with a reduced 
risk of all-cause mortality (90, 91) and two found that a Western/unhealthy diet was 
significantly associated with an increased risk of all-cause mortality (90, 92). These findings 
support the AICR/WCRF recommendations for cancer survivors to reduce intakes of fast 
foods, processed foods, red meat and sugar sweetened drinks and increase consumption of 




not reduce the risk of recurrence (HR = 0.71, 95 % CI: 0.48, 1.06) (91) and neither did a 
healthier diet (HR = 0.95, 95 % CI: 0.63, 1.43) (90), although neither of these findings were 
significant. One of the seven was able to make a connection with BC and diet when the cancer 
was analysed by subgroup. The overall diet quality of women who had estrogen receptor 
positive tumours (HR = 0.55, 95 % CI: 0.38, 0.79, ptrend = 0.0009) was more strongly 
associated with all-cause mortality than women who had estrogen receptor negative tumours 
(HR = 1.14, 95 % CI: 0.58, 2.23, ptrend = 0.811). This suggests the effects of diet quality may 
differ by tumour subtype, although there was no statistically significant interaction (p = 
0.449) (93).  
 
2.4 Conclusion  
Currently, there is insufficient evidence to create robust nutritional guidelines for BC 
survivors. This may be a potential reason why BC patients and survivors do not tend to follow 
a ‘healthy diet’. There are several ways that cancer treatment can impact nutritional status and 
a number of proposed ways to alleviate or prevent the problem. Individualised treatment plans 
with a focus on nutrition are considered the cutting edge technique in order to do this; 
however they have not been implemented in NZ. There have been ample studies around the 
world investigating the effect that diets, foods and micronutrients have on BC patients and BC 
survivors, with a large focus on fruits and vegetables. However, minimal research has been 
done on this population in NZ. The findings from these studies tend to have mixed results and 
are sometimes inconclusive. In order to make NZ specific guidelines and/or recommendations 








3. Objective Statement 
To date, there is no research on the dietary intake of Breast Cancer (BC) survivors who have 
completed treatment in New Zealand. This information is vital if nutritional support is to be 
provided to survivors, as it will provide an insight as to what these women are currently doing.  
Therefore this study will:  
1. Describe the macronutrient and micronutrient intakes of physically active BC 
survivors in Dunedin, New Zealand who are at least three months post treatment 
ceasing and compare to intakes of New Zealand adults.  
2. Describe the food group intakes of physically active BC survivors in Dunedin, New 
Zealand who are at least three months post treatment ceasing and compare to New 
Zealand recommendations.  
3. Determine whether BC treatment type has an association with macronutrient, 
micronutrient and food group intake.  
4. Determine whether time since diagnosis has an association with macronutrient, 
micronutrient and food group intake.  
5. Determine whether body mass index or tertiary education status is associated with 







4.1 Study Design 
The specific aim of this observational pilot study was to describe the dietary takes of Breast 
Cancer (BC) survivors attending the Exercise Training Beyond Breast Cancer (EXPINKT™) 
programme, who were at least six weeks post treatment. Participants completed a 
demographic questionnaire and a validated semi quantitative Food Frequency Questionnaire 




The EXPINKT™ programme provides personalised exercise opportunities that use a 
combination of resistance and aerobic training. It was developed in 2009 by Dr. Lynnette 
Jones and is based at the Otago University School of Physical Education, Sport and Exercise 
Sciences. The aims of the programme are to improve physical function, strength, 
cardiovascular health and quality of life.  
 
Clients are referred to the EXPINKT™ programme by their Medical or Radiation Oncologist, 
Radiation Therapist, or Breast Surgeon. They attend two, 40 - 45 minute sessions per week. 
The first year of their training is one-on-one with a specialised trainer and after this they are 





4.3 Ethical Approval  
Ethical approval was obtained from the University of Otago Human Ethics Committee 
(H18/057) (Appendix A). This approval covered the EXPINKT™ programme’s EFFECT 
study as well as this specific sub-study.  
 
4.4 FFQ Sub-Study 
This research was carried out as a sub study of the EXPINKT™ programme. A convenience 
sample of women from the EXPINKT™ programme were used in this study.   
 
4.4.1 Participants  
Participants from the EXPINKT™ programme, who had completed active treatment at least 
six weeks prior, were invited to participate in this sub-study. Participants were provided with 
an envelope containing an information sheet, which outlined the purpose of the study, what 
was required of the participants and what would happen with their information supplied, a 
short demographics questionnaire and a copy of the FFQ (Appendix B). Participants were 
provided with a stamped, addressed envelope to return the questionnaire to the investigators.  
 
4.4.2 Demographic Data 
The demographic questionnaire collected information on age, highest education level attained, 
relationship status, height, weight, working arrangement, income, smoking status, health 
conditions, BC diagnosis time and stage and BC treatment.  
 
4.4.3 Food Frequency Questionnaire 
The FFQ gives values for energy, 35 nutrients, as well as for the five food groups for which 




gold standard, (8, 9) but when designing a research study a pragmatic approach must be taken 
i.e. the dietary assessment method used must not only give reasonable results, but it should be 
one that participants would also undertake. In this case, after discussion with project staff and 
participants and based on previous research experience, an FFQ was deemed to be the only 
method that would work in this study. This was because although a small sample size, we did 
not have the time or resources to conduct 35, 24-hour recalls as they can take between 30-45 
minutes (9) and well trained interviewers are required (9). The participants were used to 
answering questionnaires and by giving them the option of completing the questionnaire 
themselves in their own time was deemed less intrusive than a 24-hour recall. Recalls also 
have errors in measurement due to a number of reasons related to knowledge, memory and the 
interview situation (9). Also, a validated FFQ was already available for use in this population. 
The dietary information was collected using a 60 item validated FFQ, (see the next section for 
more details) which was designed to take about 15 to 20 minutes to complete.  
 
Development of FFQ 
The FFQ used in this research was developed in 2009 (95, 96) for use in adults and was based 
on the Willet FFQ (10). It measured dietary intake over the preceding year. Foods that were 
not commonly consumed in NZ that were listed in the Willet FFQ were removed and foods 
that are commonly consumed, but were not included in the Willet FFQ were added. The 
names of some foods or brands that are not recognised in NZ were changed as well, e.g. 
“sweet peppers” was altered to “capsicum”. Foods consumed on a weekly basis by more than 
10 % of the population in the 1997 New Zealand National Nutrition Survey (97) were 
included. If items were not found in two Dunedin supermarkets they were removed. Food 
items were also grouped together if the nutrient contents were comparable (e.g. apples and 
pears), if they had the same main constituent (e.g. processed meats) or if they shared 




The Willet FFQ used nine frequency options, which was reduced to seven by combining the 4 
- 5 times per day and 6 or more times per day into 4 - 6 per day. The amount of 
supplementary questions was decreased from 24 to five. They covered dietary supplement use, 
intake of other foods not in the questionnaire, consumption of milk and fat spreads and a 
summary of intake from each food group.  
 
Pretesting 
The FFQ was pretested in a two hour focus group in August 2009 which consisted of seven 
female and male Dunedin residents aged 30 - 59. They discussed (a) the participants’ initial 
reactions and overall impressions; (b) the example page; (c) any foods not included; (d) 
serving sizes; (e) helpful features; (f) any difficulties. Their feedback assisted modifications to 
the FFQ.  
 
FFQ Validation 
The FFQ was first validated in 2012 in a population of 132 males and females aged 30 - 39 
years. The participants completed the FFQ twice, an eight day weighed food record and 
provided a blood sample. The results from the study showed that the reliability coefficients 
ranged from 0.47 for calcium to 0.83 for alcohol with most values placing between 0.60 and 
0.80. In terms of the validity coefficients for energy adjusted data, alcohol was the highest 
(0.74) followed by cholesterol (0.65) and β - carotene (0.58). The lowest nutrients were zinc 
(0.24) and calcium (0.28). The mean percentage agreement for all energy adjusted nutrients 
was 77.9 % and gross misclassification was 4.5 %. There was almost perfect mean percentage 
agreement (i.e. close to 100 with 95 % confidence intervals including 100) for energy and 
most macronutrients both before and after adjustment. The Bland-Altman analyses showed 
wide limits of agreement for all micronutrients, however high agreement was demonstrated 




coefficients were 0.34 for β - carotene and 0.33 for vitamin C when compared with 
biomarkers. The validation proved that the FFQ can administer highly repeatable 
measurements and has good validity in ranking individuals intake.  
 
In 2017, the FFQ was validated again for an intake of the preceding three months. It was 
validated in 65 participants aged 18 - 70 years. They too completed the FFQ twice and a 
seven day weighed diet record. This FFQ established good test-retest reliability with 
Spearman correlation coefficients ranging from 0.51 to 0.69, and gross misclassification 
tertile no greater than 9.2 %. The Spearman correlations ranged from 0.44 for carbohydrate to 
0.58 for total fat and monounsaturated fat demonstrating that the validity of the FFQ was 
acceptable. The highest rate of gross misclassification between the FFQ and seven day 
weighed diet record was 12.5 % for carbohydrate.  
 
4.4.4 Data Entry 
FFQ data was entered into Microsoft Excel spreadsheet (Microsoft Corporation 2010). The 
spreadsheet calculated the participants’ daily average intake of energy, 35 nutrients and the 
five food groups (94). 
 
4.5 Statistical Analysis 
All statistical analyses were done using Stata 15.1 (StataCorp, College Station, Texas). Mean 
differences between groups (treatment type, time since diagnosis, BMI status and tertiary 








5.1 Participant Characteristics  
A total of 35 out of the 50 participants from the EXPINKTTM programme who received a 
questionnaire, returned their questionnaire by the cutoff date and were therefore included in 
this pilot study; a 70 % response rate. Participant characteristics are presented in Table 5.1 - 
ages ranged from 42 to 74 years. Most participants (45 %) had a Body Mass Index (BMI) in 
the normal weight range (BMI = 18.0 - 24.9 kg/m2), while almost a third were classified as 
obese (BMI ≥ 30.0 kg/m2). The majority of women (74 %) received their cancer diagnosis 
between 2013 and 2018, while the remaining were diagnosed from 2008 to 2012. Only three 
women did not receive radiotherapy. However, 60 % received both chemotherapy and 
hormone therapy. Over 50 % of the participants had a tertiary education. Only five of the 
women were still experiencing taste changes as a result of chemotherapy (data not shown) and 
the affected foods listed were, rice, water, apples, root vegetables, salads, lettuce, sweet foods, 
tea, coffee, cereal, alcohol, broccoli, lemons and ginger. Fourteen women experienced weight 
fluctuation in the last twelve months and there was no consistency in this between women. 
Some women first gained several kilograms and then lost some, whereas other women were 
the opposite (data not shown). The net weight gained and lost ranged from a gain of 12 kg to a 
loss of 6 kg. In terms of other health concerns, six women reported having high blood 
pressure, and another six reported high cholesterol. Only one participant had diabetes and 








Table 5.1: Participant characteristics  
 Women 
(n = 35) 
Age, mean (range)  61 (42 – 74) 
Tertiary Educated, n 19 
BMI kg/m2, mean 27.0 
Employment, n  
Full time 9 
Part time  9 
Retired 13 
Volunteer  2 
Home duties 2  
Annual household income over $50,000  15 
Time of diagnosis, n  
2008 - 2012 9 
2013 - 2018 26 





Do not know/no answer 10 




Hormone therapy  21 
Treatment Regime, n  
S + C + R + H  15 
S + C + R 3  




S + R + H 
C + R + H 
S + R  
H 
0 







n = number of participants; kg/m2 = weight in kilograms divided by height in metres squared; 













Table 5.2: Mean, standard deviation, median and interquartile range for nutrient intakes from current study and mean intake of the 2008/2009 New 
Zealand Adult Nutrition Survey of selected age groups 
 Mean intake per day (SD) Median (IQR) 
ANS 08/09 Women 
31 – 50 years 
Mean Intakea 
ANS 08/09 Women 
51 – 70 
Mean Intakea 
Total energy (kJ) 9396 (2530) 9380 (8109, 10416) 7921 7205 
Carbohydrate (g) 253 (70.6) 255 (199, 287) 213 197 
Protein (g) 97.6 (28.3) 96.9 (76.5, 113) 79.0 71.0 
Total fat (g) 87.6 (31.8) 82.4 (68.4, 97.9) 74.0 66.0 
SFA (g) 35.3 (16.5) 33.1 (27.2, 39.8) 29.2 24.6 
MUFA (g) 30.9 (10.4) 29.7 (24.8, 36.2) 26.8 24.8 
PUFA (g) 13.6 (4.19) 13.3 (10.6, 16.4) 10.5 10.3 
Sugars (g) 132 (40.2) 124 (102, 159) 98.0 95.0 
Carbohydrate (% TE) 45.4 (6.41) 45.7 (41.4, 48.6) 45.5 46.2 
Protein (% TE) 17.4 (2.75) 17.2 (15.8, 19.1) 17.0 16.7 
Fat (% TE) 34.6 (5.09) 34.3 (32.0, 37.2) 34.5 34.1 
SFA (% TE) 14.2 - 13.6 12.6 
MUFA (% TE) 12.3 - 12.4 12.7 
PUFA (% TE) 5.46 - 5.0 5.3 







Vitamin A (µg) 
Vitamin C (mg) 
Vitamin B6 (µg) 









1172 (787, 1623) 
128 (105, 185) 
2.07 (1.69, 2.61) 
4.16 (3.26, 5.97) 
39.4 (34.1, 48.9) 













Thiamine (mg) 2.19 (1.92) 1.52 (1.14, 2.12) 1.2 1.2 
Folate (µg) 569 (189) 530 (418, 703) - - 
Calcium (mg) 1149 (663) 992 (799, 1284) 847 775 
Iron (mg) 15.1 (3.91) 14.5 (12.1, 17.5) 10.4 10.2 
Magnesium (mg) 437 (110) 423 (372, 508) - - 
Zinc (mg) 12.8 (4.00) 12.8 (9.93, 15.1) 10.0 9.1 
Selenium (µg) 55.6 (19.7) 58.0 (38.5, 70.7) 54.2 56.9 
Potassium (mg) 4695 (1431) 4317 (3733, 5587) 2869 2878 
SD = standard deviation; IQR = interquartile range; ANS = Adult Nutrition Survey; kJ = kilojoule; g = gram; SFA = saturated fat;  
MUFA = monounsaturated fat; PUFA = polyunsaturated fat; TE = total energy; µg = microgram; mg = milligram.  
aObtained from 2008/09 New Zealand Adult Nutrition Survey, where dietary information was derived from one 24 - hour diet recall from 746 
and 517 New Zealand women aged 31 - 50 and 51 - 70 years respectively (University of Otago and Ministry of Health 2011).   
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Table 5.3: Median and interquartile range for food group intake and comparison to New 
Zealand Ministry of Health Guidelinesa  
Food Groups Median IQR NZ Guidelinesa 
Fruit (per day) 2 (1 – 3) ≥ 2 
Vegetable (per day)  2 (2 – 3) 3 + 
Meat and Poultry (per week) 4 (3 – 6) 
≥ 7b 
Seafood (per week) 1 (1 – 2) 
Breads and cereals (per day)  1 (1 - 2) 6 + 
IQR = interquartile range; NZ = New Zealand.  
aObtained from Eating and Activity Guidelines for New Zealand Adults (Ministry of Health 
2015). 
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5.2 Nutrient and Food Group Intakes  
Table 5.2 shows mean and median energy and nutrient intakes from the current study and 
comparative values from women participants aged 31 to 70 years from 2008/2009 New 
Zealand Adult Nutrition Survey (ANS) (98). This study compared results to the ANS despite 
dietary assessment differences, to have some kind of comparative dietary intake of women of 
the same age group. Also, it shows that this FFQ has produced reasonable intakes when 
compared to the general population’s intake. Nutrient intakes obtained from the Food 
Frequency Questionnaire (FFQ) used in the current study were slightly higher than those seen 
in the ANS (98). Mean energy intake from the FFQ was 9396 kJ/d, higher than 7921 kJ/d, and 
7205 kJ/d reported by ANS participants of 31 - 50 years and 51 - 70 years respectively. 
Calcium intake from the EXPINKT™ participants was substantially greater than those 
women from the ANS. Saturated fat comprised 14 % of total energy, MUFA 12 % and PUFA 
5 %. Reported breads and cereals intake per day was one serving (Table 5.3). This low intake 
prompted investigation of the individual relevant category questions from the FFQ. The 
average intake at this level was found to be three serves per day. Of the study population 
43 % met the Ministry of Health (MOH) vegetable recommendations, 60 % met the fruit, 
40 % met the meat and seafood recommendation and 0 % met the breads and cereals.   
 
5.2.1 Average Nutrient and Food Group Intake by Subgroup 
The mean difference in energy intake for participants who had chemotherapy compared to 
those who did not have chemotherapy was 996 kJ (95 % CI: -772, 2764) and the difference 









  Table 5.4: Mean and 95 % confidence interval for nutrient intake by breast cancer treatment  
 
Chemotherapy (n = 21) versus  
no chemotherapy (n = 14)a 
Hormone therapy (n = 14) versus  
no hormone therapy (n = 21)b 
Mean (95 % CI) Mean (95 % CI) 
Energy (kJ) 996 (-772, 2764) 789 (-991, 2570) 
Carbohydrate (g) 35.8 (-12.8, 84.5) 30.8 (-18.3, 79.9) 
Protein (g) 12.8 (-6.83, 32.5) 12.6 (-7.10, 32.3) 
Fat (g) 7.46 (-15.0, 30.0) 4.17 (-18.4, 26.8) 
SFA (g) 5.58 (-6.01, 17.2) 1.73 (-10.0, 13.5) 
MUFA (g) 0.75 (-6.66, 8.17) 0.52 (-6.90, 7.94) 
PUFA (g) 0.24 (-2.74, 3.22) 1.00 (-1.96, 3.96) 
Sugars (g) 12.2 (-16.1, 40.5) 21.7 (-5.86, 49.4) 
Carbohydrate (% TE)  0.82 (-3.74, 5.38) 0.67 (-3.89, 5.23) 
Protein (% TE) 0.87 (-1.07, 2.80) 1.12 (-0.80, 3.03) 
Fat (% TE) -0.65 (-4.27, 2.97) - 0.74 (-4.36, 2.88) 
Fibre (g) 2.34 (-3.60 – 8.28) 2.87 (-3.04, 8.78) 
Vitamin A (µg) 328 (-204, 859) -50.8 (-595, 493) 
Vitamin C (mg) 16.2 (-35.5, 67.9) 3.8 (-48.1, 55.8) 
Vitamin B6 (µg) 0.32 (-0.10, 0.74) 0.25 (-0.17, 0.67) 








Niacin (mg) 3.61 (-3.40, 10.6) 3.52 (-3.50, 10.5) 
Riboflavin (mg) 0.59 (-0.11, 1.30) 0.52 (-0.19, 1.22) 
Thiamine (mg) 0.46 (-0.90, 1.82) 0.81 (-0.54, 2.15) 
Folate (µg) 71.8 (-60.1, 204) 115 (-13.4, 243) 
Calcium (mg) 396 (-54.0, 848) 369 (-85.2, 823) 
Iron (mg) 0.50 (-2.28, 3.28) 1.22 (-1.53, 3.98) 
Magnesium (mg) 41.9 (-35.8, 119) 43.4 (-33.2, 120) 
Zinc (mg) 1.74 (-1.05, 4.52) 1.88 (-0.89, 4.65) 
Selenium (µg) 3.68 (-10.3, 17.7) 0.94 (-13.1, 15.0) 
Potassium (mg) 810 (-168, 1788) 605 (-392, 1602) 
n = number of participants; CI = confidence interval; kJ = kilojoule; g = gram; SFA = saturated fat; MUFA = monounsaturated fat;  
PUFA = polyunsaturated fat; TE = total energy; µg = microgram; mg = milligram. 
aWomen who underwent chemotherapy have intakes represented as positive compared to those who did not undergo chemotherapy. 




Table 5.5: Mean and 95 % confidence interval for food group intake by breast cancer 
treatment  
 
Chemotherapy (n = 21) 
versus no chemotherapy  
(n = 14)a 
Hormone therapy (n = 14) 
versus no hormone therapy 
(n = 21)b 
Mean (95 % CI) Mean (95 % CI) 
Fruit (per day) 0.00 (-0.69, 0.69) 0.00 (-0.69, 0.69) 
Vegetables (per day) 0.87 (-0.18, 1.92) 0.39 (-0.69, 1.48) 
Meat and poultry (per week) -0.89 (-2.85, 1.08) -1.01 (-2.97, 0.95) 
Fish and seafood (per week) 0.21 (-0.59, 1.02) 0.10 (-0.71, 0.90) 
Breads (per day) 0.36 (-0.28, 1.00) 0.00 (-0.65, 0.65) 
n = number of participants; CI = confidence interval. 
aWomen who underwent chemotherapy have intakes represented as positive compared to 
those who did not undergo chemotherapy. 
bWomen who underwent hormone therapy have intakes represented as positive compared to 


















There were no meaningful differences for any nutrients between treatments. In groups of 
participants who underwent either chemotherapy or hormone therapy, nearly all of their 
nutrient intakes were greater than participants who did not receive either treatment (Table 
5.4). Differences between Breast Cancer (BC) diagnosis groups are highlighted in Table 5.6. 
Higher values were in favour of protein, riboflavin, folate, calcium, zinc and potassium and 
these nutrients confidence intervals did not cross zero. Calcium intake was significantly 
higher in the cohort of participants who were diagnosed earlier at 587 mg/d (95 % CI: 99,7, 
1074). As Table 5.7 shows, those with an earlier diagnosis consumed 0.75 pieces more fruit 
(95 % CI: 0.02, 1.48) than the later diagnosis group. There were no meaningful differences 
between nutrients and BMI or education level (Table 5.8). However, lack of a tertiary 






Table 5.6: Mean and 95 % confidence interval for nutrient intake by time since diagnosis  
 
Diagnosed prior 2013 (n = 9) versus diagnosed 2013 and after  
(n = 26)a 
Mean (95 % CI) 
Energy (kJ) 1267 (-703, 3238) 
Carbohydrate (g) 45.7 (-8.26, 99.7) 
Protein (g) 22.8 (1.64, 43.9) 
Fat (g) 8.04 (-17.2, 33.3) 
SFA (g) 6.04 (-6.96, 19.1) 
MUFA (g) 0.93 (-7.38, 9.25) 
PUFA (g)  -0.47 (-3.80, 2.87) 
Sugars (g) 19.1 (-12.3, 50.5) 
Carbohydrate (% TE) 1.40 (-3.70, 6.50) 
Protein (% TE) 1.86 (-0.24, 3.95) 
Fat (% TE) -1.29 (-5.33, 2.75) 
Fibre (g) 5.73 (-0.68, 12.1) 
Vitamin A (µg) 455 (-134, 1043) 
Vitamin C (mg) 38.6 (-18.1, 95.2) 
Vitamin B6 (µg) 0.40 (-0.07, 0.86) 









6.65 (-0.98, 14.3) 
0.88 (0.11, 1.64) 
0.25 (-1.28, 1.78) 
Folate (µg) 162 (22.4, 301) 
Calcium (mg) 587 (99.7, 1074) 
Iron (mg) 1.89 (-1.17, 4.94) 
Magnesium (mg) 73.1 (-10.6, 157) 
Zinc (mg) 3.21 (0.23, 6.20) 
Selenium (µg) 8.91 (-6.50, 24.3) 
Potassium (mg) 1153 (85.7, 2220) 
n = number of participants; CI = confidence interval; kJ = kilojoule; g = gram; SFA = saturated fat; MUFA = monounsaturated fat;  
PUFA = polyunsaturated fat; TE = total energy; µg = microgram; mg = milligram. 




Table 5.7: Mean and 95 % confidence interval for food group intake by time since diagnosis  
 
Diagnosed prior 2013 (n = 9) versus 
 diagnosed 2013 and after (n = 26)a 
Mean (95 % CI) 
Fruit (per day) 0.75 (0.02, 1.48) 
Vegetables (per day) 0.30 (-0.93, 1.52) 
Meat and Poultry (per week) -0.37 (-2.60, 1.86) 
Fish and seafood (per week) 0.33 (-0.56, 1.23) 
Breads and cereals (per day) 0.45 (-0.27, 1.16) 
n = number of participants; CI = confidence interval. 
aWomen who were diagnosed prior to 2013 have intakes represented as positive compared to 







Table 5.8: Mean and 95 % confidence interval for nutrient intake by body mass index and tertiary education status 
 
BMI < 25 kg/m2 (n = 16) versus  
BMI ≥ 25 kg/m2 (n = 18)a 
No tertiary education (n = 16) versus 
 tertiary educated (n = 19)b  
Mean (95 % CI) Mean (95 % CI) 
Energy (kJ) 203 (-1591, 1998) -55.6 (-1827, 1718) 
Carbohydrate (g) 5.17 (-45.3, 55.6) -0.68 (-50.1, 48.8) 
Protein (g) 1.88 (-18.4, 22.1) -11.8 (-31.2, 7.56) 
Fat (g) 5.90 (-16.6, 28.4) 3.81 (-18.4, 26.0) 
SFA (g) 0.63 (-11.2, 12.5) -1.46 (-13.0, 10.1) 
MUFA (g) 3.00 (-4.25, 10.3) 2.01 (-5.25, 9.28) 
PUFA (g) 1.47 (-1.40, 4.33) 2.04 (-0.81, 4.88) 
Sugars (g) 5.07 (-23.9, 34.0) -0.97 (-29.2, 27.2) 
Carbohydrate (% TE) -0.34 (-4.95, 4.26) -0.49 (-5.98, 4.00) 
Protein (% TE) 0.67 (-1.29, 2.63) -2.06 (-3.84, -0.28) 
Fat (% TE) 1.53 (-2.09, 5.15) 2.53 (-0.93, 5.98) 
Fibre (g) -0.13 (-6.17, 5.90) 1.65 (-4.22, 7.51) 
Vitamin A (µg) 149 (-393, 692) 85.6 (-449, 620) 
Vitamin C (mg) -11.7 (-63.4, 39.9) 3.14 (-48.0, 54.3) 
Vitamin B6 (µg) 0.20 (-0.23, 0.63) -0.19 (-0.61, 0.24) 






Niacin (mg) 3.45 (-3.56, 10.5) -3.49 (-10.4, 3.41) 
Riboflavin (mg) -0.30 (-1.03, 0.44) -0.40 (-1.11, 0.31) 
Thiamine (mg) -0.34 (-1.72, 1.04) -0.97 (-2.28, 0.33) 
Folate (µg) -38.4 (-174, 96.8) 63.4 (-66.7, 194) 
Calcium (mg) -332 (-795, 131) -188 (-648, 272) 
Iron (mg) 0.77 (-2.04, 3.57) -1.34 (-4.04, 1.36) 
Magnesium (mg) -12.8 (-90.8, 65.2) 21.4 (-55.1, 97.8) 
Zinc (mg) -0.04 (-2.89, 2.81) -1.43 (-4.19, 1.33) 
Selenium (µg) 16.3 (3.57, 29.08) -8.07 (-21.6, 5.43) 
Potassium (mg)  -191 (-1206, 824) -71.7 (-1074, 931) 
BMI = body mass index; kg/m2 = weight in kilograms divided by height in metres squared; n = number of participants; CI = confidence 
interval; kJ = kilojoule; g = gram; SFA = saturated fat; MUFA = monounsaturated fat; PUFA = polyunsaturated fat; TE = total energy;  
µg = microgram; mg = milligram.  
aWomen who have a BMI < 25 kg/m2 have intakes represented as positive compared to those who have a BMI ≥ 25 kg/m2. 





Table 5.9: Mean and 95 % confidence interval for food group intake by body mass index 
status and tertiary education status 
 
BMI < 25 kg/m2 (n = 16) 
versus BMI ≥ 25 kg/m2  
(n = 18)a 
No tertiary education (n = 16) 
versus tertiary educated  
(n = 19)b 
Mean (95 % CI) Mean (95 % CI) 
Fruit (per day) -0.35(-1.04, 0.33) -0.23 (-0.91, 0.44) 
Vegetables (per day) 0.50 (-0.60, 1.59) -0.12 (-1.20, 0.95) 
Meat and poultry (per week) 1.51 (-0.43, 3.44) -1.41 (-3.30, 0.48) 
Fish and seafood (per week) 0.75 (-0.02, 1.51) -0.59 (-1.35, 0.18) 
Breads and cereals (per day) -0.03 (-0.69, 0.63) -0.40 (-1.02, 0.22) 
BMI = body mass index; kg/m2 = weight in kilograms divided by height in metres squared; 
 n = number of participants; CI = confidence interval. 
aWomen who have a BMI < 25 kg/m2 have intakes represented as positive compared to those 
who have a BMI ≥ 25 kg/m2. 
bWomen who have a tertiary education have intakes represented as positive compared to those 























The results of this study show that the mean carbohydrate, protein and fat percentage of total 
energy intake in Breast Cancer (BC) survivors fall just within the New Zealand (NZ) 
Acceptable Macronutrient Distribution Ranges (AMDR) of 45 – 65 %, 15 – 25 % and 20 – 
35 % respectively (99). These results are comparable to other BC survivors. In a study in 
Canada, (100) these proportions were found to be 52 %, 18 %, and 29 % and in Malaysia, 
(31) 56 %, 15 % and 29 % respectively, although these countries used estimated three day 
food diaries to measure intake. Conversely, in the current study the mean percentage of 
saturated fat that contributes to total energy is over the < 10 % Ministry of Health (MOH) 
recommendations (94). This is well above Canada’s reported intake of 8.9 % (100) and 
Malaysia’s of 5.4 % (31).  
 
Compared to the 2008/09 Adult Nutrition Survey (ANS) (98), nearly all nutrient intakes 
appeared to be greater in the current study. However, the ANS used 24-hour recall to measure 
dietary intake, so it may be that the difference is due to methods used to assess diet, rather 
than there being a true difference in intake (8, 9). However, a recent small qualitative study in 
the United States of America (US) (101), noted that cancer survivors’ diets reflect that of the 
general US adult population day to day diet, which is abundant with high fat, sugar and 
sodium containing foods (102). While this study also reported that some participants said their 
cancer diagnosis led to healthful dietary changes, an equal number of participants had chosen 
to ‘let go’ of ‘dietary restrictions’ that they had lived by which had not guaranteed them free 
from cancer. 
 
Whether participants were meeting national recommendations for the breads and cereals food 
group was measured in two ways. It was initially measured using a supplementary question at 




consumption was calculated from the relevant food item frequency questions within the main 
body of the Food Frequency Questionnaire (FFQ). The two mean answers for this food group 
were one serving and three, respectively. The supplementary question used here was one used 
in the ANS (98), and during cognitive pre-testing it was shown that participants understood 
the meaning of the question (103). However, it may be the case, but we cannot say for certain, 
that participants in this study did not understand exactly what foods belong to the breads and 
cereals category. Therefore, it is possible that participants did not include all servings in their 
answer. It is also possible that over-reporting also occurred for the individual ‘cereal-
containing foods’ questions. Whichever measure is used, intake of breads and cereals in this 
study is below national recommendations (94). This food group is responsible for providing 
energy so that the body can perform everyday activities and maintain metabolism (94, 104). 
Inadequate breads and cereals i.e. low carbohydrate intake could contribute to fatigue (105, 
106), which can be a problem for cancer patients and survivors (30). This food group also has 
high fibre containing foods (94). Fibre is extensively researched by the AICR/WCRF for its 
potential in decreasing risk of all-cause mortality of BC survivors (18). The evidence was 
consistent but limited in showing an inverse association between fibre containing foods and 
all-cause mortality at 12 months after diagnosis (18). These low intakes highlight the need for 
nutritional treatment plans for BC survivors. 
 
In the current study, median fruit intake only just meets recommendations (94) and median 
vegetable intake is lower than recommended (94). The Women’s Healthy Eating and Living 
Study (27) was a prospective cohort study of BC survivors. The intervention group received 
nutrition advice about increasing fruits and vegetables in their diet. A greater intake was 





Women who are undergoing BC treatment have been shown to have inadequate diets due to 
their low intakes of fruit, legumes and dark green and orange vegetables. Thereby resulting in 
an inadequate intake of several micronutrients (38, 107). Dunedin women participating in the 
EXPINKT™ programme five years ago who were undergoing chemotherapy had their dietary 
intake measured using four day weighed food diaries, at three time points, before and twice 
during chemotherapy (108). Their macronutrient ranges contributing to total energy tended to 
fall only just within the NZ AMDRs (99). Carbohydrate at the three time points were 45.2 % 
to 47.1 % to 44.7 %, protein went from 15.8 %, to 14.6 % to 16.9 % and total fat 35.6 %, to 
37.0 % to 36.4 %. Average total fat was above the recommendation of 20 – 35 % (99) during 
the entire study period. Saturated fat intake ranged 12.4 to 124.6 g/d. These intakes are similar 
to the current study’s population where a different assessment method has been used and the 
women are post treatment.  
 
Results of previous research on diet quality of cancer survivors and BC survivors is 
contrasting. Cancer survivors have significantly lower healthy eating scores than people 
without cancer (32) and in general, a poor dietary intake compared to people without cancer 
(29, 109). Specifically inadequate intakes of total energy, protein and fat (110-113) as well as 
several nutrients that are often found in animal food sources such as vitamin A, B vitamins 
and phosphorus (114). BC survivors have been found to have low protein intake as well as a 
poor intake for a number of micronutrients and minerals when compared to people who have 
never been diagnosed with cancer (114). This differs from the current study where protein 
intake was within recommendations, albeit at the lower end of the AMDR (99). Zhang et al. 
proposed that BC survivors have the best diet quality among other major cancer types (32). 
They have been shown to increase their fruit and vegetable significantly more so than cancer 
free women (115, 116) and to decrease total and saturated fat consumption after their 




recommendations met after their diagnosis and surpass those met by cancer free women 
significantly (116).  
 
A review (117) of the combined effects of dietary intake and exercise on BC survivors did not 
find evidence to support a decreased risk of cancer recurrence, despite the overall positive 
influence of changes in these lifestyle components.  
 
It is difficult to identify an ‘average’ duration for BC treatment as each case differs (6). 
Individuals are typically considered to be ‘cancer free’ if there has been no recurrence or 
metastases diagnosed in the five-year period following diagnosis (118-120). While treatments 
are effective, the late and long-term side effects of cancer treatment are known to include 
weight gain, (42) fatigue, cognitive limitations, depression and anxiety (57). There is seldom 
mention of an impact on nutritional intake or status.  
 
Various measures are encouraged to offset the adverse side effects of treatment; however, 
post-treatment benefits of nutrition and diet are often ignored. Despite this, cancer patients 
diagnosed over five years prior to assessment have been found to meet more nutrition 
recommendations than those diagnosed two to four years prior (101). Those diagnosed earlier 
were also found to have healthier eating index scores (101). Fruits and vegetables are 
consumed more so in women diagnosed with BC earlier (116). However, no significant 
differences in cancer survivors’ health behaviours were reported when categorised by time 
since diagnosis in a US study (121). Women in the current study diagnosed with BC more 
than five years ago tended to have greater intakes of almost all nutrients compared to those 
diagnosed within five years, with meaningfully greater intakes of protein, riboflavin, folate, 
calcium, zinc and potassium. These nutrients are abundant in animal products such as meat, 




is approximately, two sausages, a piece of fish, 2/3 cup of chicken, four eggs, 1 ½ cups lentils 
and 300 g tofu. The difference between the two groups may be because women are more 
relaxed about their diet several years after diagnosis. Therefore they may consume as much of 
whatever foods they prefer as they no longer want to live within diet restrictions, much like 
the cancer survivors reported by Klassen et al. (101). Perhaps by this time, women know what 
their body needs in order to function the way they like and so consume what they like, or 
maybe they are trying to meet a self-determined pre diagnosis weight; however, these are all 
just theories. There are theories that health behaviour changes may not relate to the entire 
cancer survivor population or that they may only be temporary (122). Guidance for nutritional 
intake after treatment could potentially prevent these significant differences.  
 
The differences within nearly all of the ‘time since diagnosis’ nutrients are greater than 10 % 
of the mean intake for the cohort. This is a large difference and if the sample size had been 
greater it is likely it would have been a significant difference.  
 
There is a great deal of research and evidence that nutritional intake is altered during cancer 
treatment. However, research on post-treatment changes is limited. A large number of BC 
patients undergoing chemotherapy (37) consumed less than the recommended amount for a 
number of micronutrients and the majority of women fell into the category of “diet requires 
modification”. Most side effects of treatment that impact eating, tend to disappear after 
treatment ceases (123). For women who had recently finished chemotherapy treatment, no 
significant differences were found in diet quality compared to those who had not (124). To 
our knowledge only one study has compared nutrient intake by treatment type of 
chemotherapy, radiation therapy and hormonal therapy and found no significant difference 




Most nutrient intakes were not affected by BMI status in this study. Obese women with BC 
have poorer survival compared to those who are non-obese (46). BC patients who consume a 
more Western diet have significantly higher BMI’s (90). In women recently having completed 
BC treatment, better diet quality scores were strongly associated with lower inflammatory 
blood markers; however, the correlation was attenuated following adjustment for BMI (124). 
This indicates that BMI may indirectly be related to the benefits of a healthy diet and 
subsequent anti-inflammatory properties (125). 
 
Although the current study found no significant differences in nutrient intake by educational 
status, other studies observed an effect. In both cancer survivors (32) and BC survivors (126) 
who had received some tertiary education, they had significantly higher ‘healthy’ diet 
measures than those who did not.  
 
The current study has a number of strengths. This is the first study conducted in New Zealand 
to measure the dietary intake of BC survivors. The FFQ used in this study was based on the 
renowned Willet FFQ (10) and developed for and validated in Dunedin adults in 2017 (16). It 
shows good reliability and validity for all nutrients, and has been shown to give accurate 
information at the individual level for macronutrients (16).  
 
This study has several limitations. This was an observational study in a convenience sample. 
It is likely that the sample size was too small to see significant differences between the 
subgroups. It is hard to evaluate the power of the study, as there are not any other studies that 
can be used to estimate the power needed. The cohort of women in this study may also be 
more likely to consume a healthier diet due to the exercise and wellbeing part of the 
programme that they were recruited from (127, 128). This may limit the generalisability of the 




desirability bias may have occurred whereby some participants may have exaggerated their 
intakes of some foods and under reported the amount of others, potentially skewing results. 
Although the questionnaire was anonymous so participants may have felt less inclined to do 
so. The use of an FFQ to measure dietary intake may have led to over-estimation of dietary 
intake, a key problem with FFQs (8, 9). Albeit, this FFQ has been shown to provide accurate 
levels of energy and nutrients in the general population (15, 16). Ideally it would have been 
best to use a weighed diet record as they are considered the ‘gold standard’ for measuring 
dietary intake, despite still having limitations (8, 9). However, a FFQ was chosen to reduce 
burden for the participant.  
 
6.1 Conclusion  
This study is the first NZ study to measure dietary intake in BC survivors. The results 
generated are designed to serve as a pilot to direct further studies in this country with a larger 
sample size and with the use of diet records. They are therefore exploratory in nature. There 
appears to be a worldwide lack of nutritional guidance and input for patients undergoing BC 
treatment and those who have finished treatment. The results of this study show the low 
dietary intakes of BC survivors in the Dunedin EXPINKT™ population compared to the 
MOH and the American Institute Cancer Research/World Cancer Research Fund 
recommendations. Survivors should have nutritional guidance at this stage of their cancer 
journey due to the problems that can arise concurrently with treatment and impact their 
nutritional status, which can have negative ramifications. Studies have documented the desire 
of nutrition input at this time from survivors. This area would benefit from further research in 
NZ, perhaps of the dietary changes endured from diagnosis to treatment ceasing, and the years 
after. Intervention studies of what women can do after treatment in relation to their nutrition, 
for the purpose of creating specific national guidelines and reducing recurrence risk is another 




7. Application to Practice 
Women who have completed treatment for Breast Cancer (BC) should be consuming a diet 
that will be of benefit to their health and this study has exposed the potential heightened risk 
of inadequacies. This highlights where the role of a dietitian would be of great help. There is a 
lot of dietary information easily available to the public, and therefore BC survivors, that is 
often misguided and can lack scientific evidence. This in turn can create a greater need for 
dietitians.  
 
Dietary changes are one of the most common lifestyle alterations made by BC survivors and 
this is a stage when patients are most ready to learn (19). Guidance by a dietitian for these 
changes would be ideal. BC and its treatments can have multiple negative impacts on the 
body, which may include poor dietary intake and weight change. These can weaken the 
patient’s nutritional status and indirectly affect postoperative complications and mortality (33-
35). Therefore, a nutritional assessment after diagnosis and after treatment by a dietitian could 
increase the patient’s chance of developing positive habits, behaviours and outcomes.  
 
Studies have shown that BC patients and cancer patients in general would have liked more 
dietetic input during their treatment (20, 25). The current study has shown what these women 
are consuming after treatment, which better equips dietitians about where to help and how to 
best target interventions in a clinical or public health setting.  
 
The results of this thesis reinforce the need for dietetic care of cancer patients. Maintaining 
nutritional status in this population could in turn decrease pressure on the health care system 
in the long term by reducing hospital admissions and reducing the risk of recurrence. 




available and cancer patients should be provided dietetic service throughout their treatment 
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Information Sheet for Participants  
Food Frequency Questionnaire 
Thank you for showing an interest in this project. Please read this information sheet carefully 
before deciding whether or not to participate. If you decide to participate we thank you. If you 
decide not to take part there will be no disadvantage to you and we thank you for considering 
our request.  
What is the aim of the project? 
The American Cancer Society recommends that after cancer treatment, patients consume a 
diet that helps maintenance of a healthy weight. This diet should be low in alcohol, high in 
fruit and vegetables and low in saturated fat. Recent research suggests that a higher intake of 
vegetables, in particular, may have a helpful effect on recurrence or survival for breast cancer. 
However, some of the treatments for different types of breast cancer can lead to changes 
affecting the ability of patients to accept and/or digest certain foods. There are currently no 
data from New Zealand populations that describe the dietary intake of breast cancer survivors.  
Therefore we would like to, describe the dietary takes of those participants from the Exercise 
Training Beyond Breast Cancer (EXPINKT) programme, who are at least 6 weeks post 
treatment.  
In order to do this, we have developed a questionnaire about the frequency of how often you 
consume different types of foods. The questionnaire will take approximately 15 – 20 minutes 
to complete. Questionnaires will be de-identified, meaning that the obtained information will 
not lead to the identification of specific individuals.  
What types of participants are being sought?  
We are looking for current participants of the EXPINKT program, who are willing to 
complete a questionnaire about their dietary intake over the last 3 months.  
Participation in this study is voluntary and there will be no financial compensation for 
participation.  
What will participants be asked to do?  
Should you ask to agree to take part in this project, you’ll be invited to take a questionnaire 
home from the gym to complete and return by mail by Dr Jones in a stamped, addressed 
envelope. Completing the questionnaire will take approximately 15-20 minutes.  
The questionnaire will ask you about the frequency of how often you have consumed specific 
foods over the last 3 months and the brands of some foods.  
Please be aware that you may decide not to take part in the project without any disadvantage 
to yourself.  
 
What will be made of the information collected? 
Answers to the questionnaire will be analysed to see if there are any patterns in the nutrient 
intake among participants. 
Data will be de-identified, e.g. you will not be individually identifiable and your responses 




The data collected will be securely stored in such a way that only the research team will be 
able to gain access to it. Data obtained as a result of the research will be retained for 10 years 
in secure storage, after which it will be destroyed.  
The results of the project may be published and will be available in the University of Otago 
Library (Dunedin, New Zealand) but every attempt will be made to preserve your anonymity. 
Regardless of whether you choose to participate, please let us know if you would like a 
summary of the findings. To receive a summary, contact Dr. Lynnette Jones 
Can Participants change their mind and withdraw from the project? 
Upon completion of the questionnaire, there is no more opportunity to correct the 
questionnaire. You may withdraw from participation in the project at any time, and without 
any disadvantage to yourself, until the final data analysis has been conducted. 
What if any participants have any questions?  
If you have any questions about our project, either now or in the future, please feel free to 
contact:  
 
Dr Lynnette Jones 
School of Physical Education, Sport and Exercise Sciences  
Email: lynnette.jones@otago.ac.nz 
Phone: 479 8962 
 
This study has been approved by the University of Otago Human Ethics Committee (Health, 
H18/057). If you have any concerns about the ethical conduct of the research you may 
contact the Committee through the Human Ethics Committee Administrator (phone +64 3 
479 8256 or email gary.witte@otago.ac.nz). Any issues you raise will be treated in 















Information Sheet for Participants  
Food Frequency Questionnaire 
 
Thank you for showing an interest in this project. Please read this information sheet carefully 
before deciding whether or not to participate. If you decide to participate we thank you. If you 
decide not to take part there will be no disadvantage to you and we thank you for considering 
our request.  
 
What is the aim of the project? 
 
The American Cancer Society recommends that after cancer treatment, patients consume a 
diet that helps maintenance of a healthy weight. This diet should be low in alcohol, high in 
fruit and vegetables and low in saturated fat. Recent research suggests that a higher intake of 
vegetables, in particular, may have a helpful effect on recurrence or survival for breast cancer. 
However, some of the treatments for different types of breast cancer can lead to changes 
affecting the ability of patients to accept and/or digest certain foods. There are currently no 
data from New Zealand populations that describe the dietary intake of breast cancer survivors.  
 
Therefore we would like to, describe the dietary takes of those participants from the Exercise 
Training Beyond Breast Cancer (EXPINKT) programme, who are at least 6 weeks post 
treatment.  
 
In order to do this, we have developed a questionnaire about the frequency of how often you 
consume different types of foods. The questionnaire will take approximately 15 – 20 minutes 
to complete. Questionnaires will be de-identified, meaning that the obtained information will 
not lead to the identification of specific individuals.  
 
What types of participants are being sought?  
We are looking for current participants of the EXPINKT program, who are willing to 
complete a questionnaire about their dietary intake over the last 3 months.  
 
Participation in this study is voluntary and there will be no financial compensation for 
participation.  
 
What will participants be asked to do?  
Should you ask to agree to take part in this project, you’ll be invited to take a questionnaire 
home from the gym to complete and return by mail by Dr Jones in a stamped, addressed 
envelope. Completing the questionnaire will take approximately 15-20 minutes.  
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The questionnaire will ask you about the frequency of how often you have consumed specific 
foods over the last 3 months and the brands of some foods.  
Please be aware that you may decide not to take part in the project without any disadvantage 
to yourself.  
 
What will be made of the information collected? 
Answers to the questionnaire will be analysed to see if there are any patterns in the nutrient 
intake among participants. 
 
Data will be de-identified, e.g. you will not be individually identifiable and your responses 
will never be linked to overall outcomes.  
 
The data collected will be securely stored in such a way that only the research team will be 
able to gain access to it. Data obtained as a result of the research will be retained for 10 years 
in secure storage, after which it will be destroyed.  
 
The results of the project may be published and will be available in the University of Otago 
Library (Dunedin, New Zealand) but every attempt will be made to preserve your anonymity. 
 
Regardless of whether you choose to participate, please let us know if you would like a 
summary of the findings. To receive a summary, contact Dr. Lynnette Jones 
 
Can Participants change their mind and withdraw from the project? 
 
Upon completion of the questionnaire, there is no more opportunity to correct the 
questionnaire. You may withdraw from participation in the project at any time, and without 
any disadvantage to yourself, until the final data analysis has been conducted. 
 
What if any participants have any questions?  




Dr Lynnette Jones 
School of Physical Education, Sport and Exercise Sciences  
Email: lynnette.jones@otago.ac.nz 
Phone: 479 8962 
 
Please make sure that you put a tick in every line of the food frequency questionnaire 






This study has been approved by the University of Otago Human Ethics Committee (Health, 
H18/057). If you have any concerns about the ethical conduct of the research you may 
contact the Committee through the Human Ethics Committee Administrator (phone +64 3 
479 8256 or email gary.witte@otago.ac.nz). Any issues you raise will be treated in 











1. What is your age? __________ 
 
2. What is your highest education qualification?  
 ☐ None 
 ☐ Secondary School (e.g. NZ School Certificate, NCEA, NZ Sixth Form Certificate, 
NZ            University Bursary/Scholarship) 
☐ Bachelor’s Degree 
☐ Masters 
☐ PhD 
☐ MD/MB ChB 
☐ Other (please specify) ___________________________________   
 
3. Are you…  




☐ Defacto/Living together  
☐ Widowed 
 
4. How tall are you? _________ (cm)    (tick this box if you are unsure/don’t want to answer) 
☐  
 
5. How much do you weigh? _________ (kg) (tick this box if you are unsure/don’t want to 
answer) ☐ 
 
6. Has your weight fluctuated in the last 12 months?  
 ☐ No 
 ☐ Yes, I lost weight (how much) ___________ (kg) 
 ☐ Yes, I gained weight (how much) ___________ (kg)  
 ☐ I’m unsure/don’t want to answer this question  
 
7. What is your main work arrangement?  
 ☐ Employed/Self employed – full-time   ☐ Student 
 ☐ Employed/Self employed – part-time  ☐ Unemployed or looking for 
work 
 ☐ Employed/Self employed – casual  ☐ Retired  
 ☐ Full – time home duties     ☐ Permanently ill/unable to 
work  
 ☐ Unpaid work in a family business or farm  ☐ Unpaid voluntary worker  
 




8. Could you provide us with an estimate of your total household income (before tax)?  
 
☐ Zero income  ☐ $1 - $5,000   ☐ $5,001 - $10,000   ☐ $10,001 
- $15,000 
 
☐ $15,001 - $20,000  ☐ $20,001 - $25,000  ☐ $25,001 - $30,000  ☐ $30,001 
- $35,000 
 
☐ $35,001 - $40,000  ☐ $40,001 - $50,000  ☐ $50,001 - $60,000   ☐ $60,001 
- $70,000 
 
☐ $70,001 - $100,000   ☐ $100,001 - $150,000 ☐ $150,001 or more   
 
☐ I would rather not answer this question  
 
9. When were you diagnosed with breast cancer? (approximately)  
 
 ___________ (month)  _____________ (year)  
 
10. What cancer stage did you have at diagnosis?  
 ☐ I   ☐ III    
 ☐ II   ☐ IV   ☐ Don’t know  
 
11. Have you previously been diagnosed with any other cancer than breast cancer?  
 ☐ Yes  ☐ No 
 
12. What treatment(s) have you had (tick all that apply) for breast cancer?  
 ☐ Surgery 
☐ Chemotherapy 
 ☐ Radiotherapy 
 ☐ Hormone treatment 
 ☐ Don’t know 
 ☐ Other (please specify) -
____________________________________________________ 
 
13. Do you currently smoke? 
☐ Yes   
☐ Quit within the last 2 years 
☐ Quit over two years ago 
☐ Never  
 
14. Have you had, or do you have any of the following conditions? (tick all that apply)  
 ☐ High blood pressure ☐ High blood glucose ☐ High cholesterol  
 ☐ Diabetes   ☐ Heart attack  ☐ Stroke 
 ☐ Emphysema  ☐ Chronic bronchitis  ☐ Arthritis/degeneration  
 ☐ Thyroid condition  ☐ Peripheral vascular disease☐ Angina (chest pain) 
 ☐ Cardiovascular disease ☐ Osteoporosis  ☐ Asthma 
 ☐ Inflammatory condition  
 
☐ Other ________________________________ 
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